Indeed, CD44 has been amply reported as a marker that identifies breast cancer cells with a pronounced self-renewal and metastatic potential [33] and, interestingly, circulating tumor cells endowed with metastatic capabilities have been shown to highly express the CD44 isoform variant, CD44v6 [34]. This evidence concerns the gene CD44 and neoplasm.